IQVIA Expands Veeva Partnership with Enterprise-Wide Clinical Operations Adoption
Event summary
- IQVIA has selected Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standards for its clinical development studies, expanding its existing partnership with Veeva.
- The move builds on a previously announced EDC partnership between the two companies.
- All Veeva clinical solutions will be available through IQVIA for sponsors looking to implement a full Veeva technology stack.
- IQVIA has approximately 94,000 employees across over 100 countries.
- Veeva serves more than 1,500 customers, ranging from large pharmaceutical companies to emerging biotechs.
The big picture
This partnership expansion reflects the growing industry trend toward integrated technology solutions in clinical research, aiming to increase trial speed and efficiency. The collaboration between IQVIA, a global leader in clinical research services, and Veeva, a dominant player in life sciences cloud applications, positions them to capture significant market share in the rapidly evolving clinical operations software market. The strategic alliance underscores the importance of frictionless technology integration in accelerating drug development and improving patient outcomes.
What we're watching
- Integration Challenges
- How IQVIA and Veeva will manage the seamless integration of their respective technologies across global clinical operations.
- Market Share Impact
- Whether this expanded partnership will accelerate Veeva's market share growth in the clinical operations software space.
- Customer Flexibility
- The extent to which customers will leverage the flexibility to choose between IQVIA's and Veeva's technology solutions.